4
Changes in Ownership
Ensysce Biosciences, Inc. Filed Acc 0001493152-22-015294
Chief Executive Officer bought 97,000 shares at an average $0.50 ($48,299)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirkpatrick Lynn Chief Executive Officer | 2022-05-25 | Purchase | +70,000 | $0.49 | $34,083 | 354,851 | D |
| Kirkpatrick Lynn Chief Executive Officer | 2022-05-26 | Purchase | +27,000 | $0.53 | $14,216 | 381,851 | D |
| Derivatives | |||||||
| Kirkpatrick Lynn Chief Executive Officer | 2022-02-17 | Grant or award · Stock Option | +200,000 | 2,516,939 | D | ||
| Open-market purchases · 97,000 sh · avg $0.50 · $48,299 | |||||||
Loading xslF345X03/ownership.xml…